NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
11.90
-0.27 (-2.22%)
At close: Dec 5, 2025, 4:00 PM EST
11.50
-0.40 (-3.36%)
After-hours: Dec 5, 2025, 6:11 PM EST
NeoGenomics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for NeoGenomics stock have an average target of 12.56, with a low estimate of 8.00 and a high estimate of 22. The average target predicts an increase of 5.55% from the current stock price of 11.90.
Analyst Consensus: Buy
* Price targets were last updated on Sep 12, 2025.
Analyst Ratings
The average analyst rating for NeoGenomics stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 2 | 1 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +0.84% | Sep 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $6.5 → $11 | Buy | Maintains | $6.5 → $11 | -7.56% | Sep 2, 2025 |
| Needham | Needham | Strong Buy Maintains $8 → $14 | Strong Buy | Maintains | $8 → $14 | +17.65% | Aug 29, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $11 | Buy | Maintains | $12 → $11 | -7.56% | Aug 4, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | -32.77% | Jul 30, 2025 |
Financial Forecast
Revenue This Year
732.58M
from 660.57M
Increased by 10.90%
Revenue Next Year
804.96M
from 732.58M
Increased by 9.88%
EPS This Year
0.09
from -0.62
EPS Next Year
0.17
from 0.09
Increased by 88.63%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 766.7M | 847.5M | ||||
| Avg | 732.6M | 805.0M | ||||
| Low | 708.6M | 769.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 16.1% | 15.7% | ||||
| Avg | 10.9% | 9.9% | ||||
| Low | 7.3% | 5.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.13 | 0.32 | |||
| Avg | 0.09 | 0.17 | |||
| Low | - | -0.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 257.1% | |||
| Avg | - | 88.6% | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.